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Bimolecular Complex between Rolling and Firm
Adhesion Receptors Required for Cell Arrest: CD44
Association with VLA-4 in T Cell Extravasation
normal T cells through the T cell receptor induces acti-
vated CD44 and attendant primary adhesion (DeGren-
dele et al., 1997a, 1997b; Lesley et al., 1994) and facili-
tates the extravasation of activated T cells into an
inflamed peritoneal site (DeGrendele et al., 1997b). The
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5323 Harry Hines Boulevard presence of circulating T cells bearing activated CD44
Dallas, Texas 75390 correlates highly with exacerbations of major autoim-
mune disease in humans (Estess et al., 1998). CD44 has
further been shown to have a role in a number of murine
models of autoimmune disease (Brocke et al., 1999;Summary
Mikecz et al., 1995; Weiss et al., 2000). We have pro-
posed that the CD44-initiated pathway is utilized primar-CD44 on activated T cells can initiate contact and medi-
ily by activated T cells for egress into a variety of in-ate rolling on hyaluronan on endothelial cells. We have
flamed tissues, consistent with these observations.shown that the integrin VLA-4 is used preferentially
For CD44-mediated primary adhesion to be physio-over LFA-1 in conjunction with this rolling interaction
logically meaningful for extravasation, it must be associ-for firm adhesion. Here, we show by coimmunoprecipi-
ated with a receptor/ligand pair capable of mediatingtation and transfection studies that CD44 associates
subsequent firm adhesion. We have demonstrated thatwith VLA-4 but not LFA-1 on the plasma membrane of
the integrin VLA-4, in conjunction with its endothelialimmune cells. Absence of the cytoplasmic portion of
ligand VCAM-1, is preferentially used in secondary ad-CD44 abrogates this coassociation and attendant firm
hesion following CD44-mediated rolling of activated nor-adhesion. Moreover, in an in vivo model of lymphocyte
mal T cells in vitro and in an in vivo model (Mohamadza-homing, cells expressing only the truncated form of
deh et al., 1998; Siegelman et al., 2000). The CD44/VLA-4CD44 together with VLA-4 fail to traffic to an inflamed
site, thereby defining a discrete biological role for the association was particularly notable since the LFA-1
cytoplasmic domain. These studies demonstrate a on these T cells was in its functional ligand binding
molecular mechanism whereby coanchoring within a conformation. These results suggested that the extrava-
single bimolecular complex between a primary and sation of activated T cells initiated through CD44/HA-
secondary adhesion molecule regulates a cell’s ability mediated primary adhesion results preferentially from
to firmly adhere, providing a fundamental alteration to VLA-4-mediated firm adhesion.
the paradigm of leukocyte extravasation. As with CD44, the VLA-4/VCAM-1 interaction has been
implicated in lymphocyte/endothelial interactions in a
wide spectrum of chronic inflammatory conditionsIntroduction
(Baron et al., 1993, 1994; Laffon et al., 1991; van Dinther-
Janssen et al., 1991; Yednock et al., 1992). Our priorAppropriate site-specific leukocyte traffic from blood
evidence in a contact hypersensitivity response sug-into tissues during the course of an immune or inflamma-
gested that this integrin operates at the level of effectortory response is the direct consequence of complemen-
T cells, which are in turn necessary for the recruitment oftary ligand interactions acting in concert in an ordered
nonspecific effector cells (Catalina et al., 1999). Recentand specific manner (Butcher and Picker, 1996; Springer,
clinical trials of a recombinant anti-4 monoclonal anti-1994). The current view of leukocyte extravasation is
body in multiple sclerosis and separately in Crohn’sthat it begins with initial contact and rolling of leukocytes
disease have shown impressive efficacy in two diverseon vascular endothelium, followed by firm adhesion
chronic inflammatory conditions (Ghosh et al., 2003;largely due to heterodimeric integrins interacting with
Miller et al., 2003). Our studies demonstrating a func-their endothelial cell ligands (Butcher and Picker, 1996;
tional coupling of CD44 and VLA-4 are suggestive thatSpringer, 1994). In recent years, this model has been
the lymphocyte trafficking roles attributed to VLA-4 mayrefined in recognition of the overlapping roles that many
of these receptors share in adhesion pathways, resulting in some situations be the result of a pathway initiated
in some blurring of the paradigm of discrete separable by interactions of CD44 tethering and rolling on endothe-
events governed by individual ligand pairs (Forlow et lial HA (Siegelman et al., 2000).
al., 2000; Jung et al., 1998). The current studies address the basis for the preferential
Our laboratory has expanded the molecular partici- functional linkage between CD44 and VLA-4. Biochemical
pants in lymphocyte recruitment to include a primary evidence supports that CD44 and VLA-4 coassociate in
adhesion interaction between the activated ligand bind- the plasma membrane and that this association is de-
ing form of CD44 on lymphocytes and its major ligand pendent on the cytoplasmic portion of CD44. Moreover,
hyaluronan (HA) on endothelium and has shown that in the absence of such physical anchoring in a bimolecu-
this interaction can be used by activated T lymphocytes lar complex, initial capture and primary adhesion can
for extravasation at sites of inflammation. Activation of proceed, but firm adhesion is abrogated. These results
describe a discrete function for the cytoplasmic domain
of CD44 and demonstrate the requirement for physical*Correspondence: siegelman@pathology.swmed.edu
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coanchoring of primary and secondary adhesion mole- above. As shown in Figures 1E and 1F, CD44 and VLA-4
also associate in SEB-activated LNC. These results sub-cules operating within a particular adhesion pathway,
one in which both participants are highly correlated with stantiate that in vivo as well as in vitro activation is
accompanied by the association of CD44 and VLA-4.chronic inflammatory processes.
The Cytoplasmic Tail of CD44 Is EssentialResults
for the Physical Association of CD44 with VLA-4
The role of the cytoplasmic portion of CD44 has beenCD44 Is Physically Associated with VLA-4 but Not
extensively investigated with respect to a number ofLFA-1 on Mouse and Human Lymphoid Cells
CD44 ligand binding and localization/signaling func-To test the hypothesis that a physical association ac-
tions, and in many respects the function remains unclearcounted for the preferential functional association ob-
(Legg and Isacke, 1998; Lesley et al., 1992; Perschl et al.,served between activated CD44 and VLA-4, we con-
1995; Pure et al., 1995; Thomas et al., 1992; Yonemura etducted coimmunoprecipitation experiments using a
al., 1998). Three cell lines were used to examine the roleselection of lymphoid cell lines as well as normal
of the cytoplasmic domain of CD44 in mediating thelymphoid cells. BW5147 constitutively expresses acti-
association with VLA-4 (Figure 2). The AKR-WT transfec-vated CD44 as measured by Fl-HA binding, while the
tant expresses full-length standard CD44, while AKR-other murine line, SAKR, human U937, KCA, and murine
TL cells express CD44 truncated at amino acid 296,lymph node cells (LNC) all express high levels of acti-
leaving only six residues of the cytoplasmic tail (Lesleyvated CD44 after phorbol myristic acid (PMA)/ionomycin
et al., 1992). BW5147 cells express the standard formactivation. In addition, all cells except BW5147 express
of CD44, and all three constitutively bind Fl-HA and rollsubstantial levels of both VLA-4 and LFA-1 (Siegelman
under shear stress on HA-coated plates (DeGrendele etet al., 2000). Cells were analyzed by reciprocal immuno-
al., 1996) (Figure 4A). BW5147 expresses the integrin 1precipitation analysis after PMA/ionomycin stimulation
chain, presumably in association with an integrin  chain(to assure fully activated integrin status) for potential
other than 4, but none of the cells express intact VLA-4.association between CD44 and VLA-4. Membrane prep-
Cells were transfected with CD49d (BW5147) or CD49darations were solubilized in CHAPS detergent, favoring
plus CD29 (AKR lines) to generate cells expressing bothstabilization of protein associations (Labeta et al., 1988),
CD44 and VLA-4 (Figure 2). Expression of LFA-1, asand were precipitated with anti-CD44, anti-VLA-4, or
measured by CD11a staining, was variable amonganti-LFA-1. Pellets were electrophoresed on reducing
these lines.10% SDS polyacrylamide gels and transferred to nitro-
Coimmunoprecipitation analyses were performed us-cellulose. Blots were then probed with antibody to one
ing the transfected cell lines expressing CD44 in combi-of the other receptors. Anti-VLA-4 precipitates probed
nation with VLA-4, as above. CD44 was detected inwith anti-CD44 gave rise to an 85 kDa band consistent
anti-VLA precipitates from SAKR, AKR-WT, and BWwith the hematopoietic (standard) form of CD44 (Figure
(Figure 3A). No band was present in AKR-TL although1A). Only BW5147 cells, which express neither VLA-4 nor
cell surface staining indicated similar levels of bothLFA-1, were negative. In reciprocal experiments (Figure
CD44 and VLA-4 (Figure 2), and the VLA-4 was shown1B), CD44 immunoprecipitates were positive with the
to be intact by reprobing with anti-VLA-4 (data notintegrin-detecting antibody, with bands at 150 kDa cor-
shown). Thus, only those cells expressing VLA-4 in con-responding to full-length VLA-4  chain and at 80 kDa,
junction with full-length CD44 demonstrated physicalconsistent with the reported size for the major degrada-
association between the two molecules. Reciprocal pre-tion product of the 4 chain (Holzmann et al., 1989).
cipitations confirmed these results, with no VLA-4bandAgain, no bands are seen in BW5147 precipitates. These
visible in AKR-TL anti-CD44 precipitates (Figure 3B).data strongly suggest that a physical association exists
These data were confirmed on two additional indepen-between CD44 and VLA-4.
dent clones of AKR-TL and are consistent with theWhen precipitating with anti-human or mouse LFA-1,
interpretation that the cytoplasmic tail of CD44 is essen-no bands corresponding to CD44 were seen in any sam-
tial for CD44/VLA-4 association.ple (Figure 1C), although all cells except BW5147 ex-
press LFA-1 at levels comparable to VLA-4 (Siegelman
et al., 2000; data not shown). Rehybridization with poly- The Cytoplasmic Domain of CD44 Is Essential
for VLA-4 Function in Firm Adhesion followingclonal rabbit anti-LFA-1 antiserum confirmed the pres-
ence of an LFA-1 L band in all appropriate lanes (Figure CD44-Initiated Primary Adhesion
To directly examine the contribution of the cytoplasmic1C, lower panel). Furthermore, in reciprocal experi-
ments, no bands were detected with anti-LFA-1 in anti- domain of CD44 to firm adhesion following CD44-initi-
ated rolling under laminar flow, plates were coated withCD44 immunoprecipitates (Figure 1D). Thus, the physi-
cal association found between CD44 and VLA-4 does HA plus either VCAM-1 or ICAM-1, as previously de-
scribed (Siegelman et al., 2000). At the concentrationsnot extend to CD44 interactions with LFA-1, demonstra-
ting that the association with VLA-4 is selective. used, no adhesive interactions were seen with VCAM-1
or ICAM-1 alone, consistent with previous reports (AlonTo determine if in vivo-activated lymph node cells
show similar CD44/VLA-4 membrane association, mice et al., 1995; Siegelman et al., 2000). As shown in Figure
4A, AKR-WT cells expressing full-length activated CD44were injected i.p. with 50 g of staphylococcal entero-
toxin B (SEB) and mesenteric lymph nodes (MLN) were roll on HA but do not exhibit firm adhesion on HA 
VCAM-1. On HA-coated plates, AKR-WT rolling num-harvested 20 hr later. Anti-CD44 and anti-VLA-4 immu-
noprecipitations and Western blots were performed, as bers are similar to those observed with AKR-WT and
Physical Association of CD44 and VLA-4 in Adhesion
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Figure 1. Coprecipitation of CD44 with VLA-4
Demonstrates Physical Association between
the Two Molecules on Activated Human and
Mouse Cells
Cells were stimulated for 18 hr using PMA
plus ionomycin, and membranes were pre-
pared as described. Lysates were precipi-
tated with primary antibody, electrophoresed
under reducing conditions, and, following
transfer to nitrocellulose membranes, blots
were probed with developing antibody fol-
lowed by SA-POD or goat anti-rabbit IgG-HRP.
(A) Anti-CD44 reacted with a band of 85 kDa in
anti-VLA-4 immunoprecipitates from mouse
peripheral LNC, SAKR, U937, and KCA.
(B) Anti-VLA-4 detected bands correspond-
ing to the 150 kDa VLA-4  chain and its 80
kDa degradation product in anti-CD44 immu-
noprecipitates from murine LNC, SAKR,
U937, and KCA but not in BW5147.
(C) No bands were detected with anti-CD44
in anti-LFA-1 immunoprecipitates. (Lower
panel) Reprobing of the same blot with rabbit
polyclonal anti-LFA-1 (mouse and human)
plus goat anti-rabbit IgG-HRP, confirming the
presence of LFA-1.
(D) No LFA-1 bands were detected in anti-
CD44 immunoprecipitates from any lysate.
(E and F) Precipitation analysis of in vivo SEB-
activated lymph node cells confirms the CD44
association with VLA-4. (E) CD44 is detected
in anti-VLA-4 precipitates from SEB-acti-
vated LNC and SAKR but not from AKR-1. (F)
VLA-4 is detected in anti-CD44 precipitates
from SEB-activated mesenteric LNC and
SAKR but not from AKR-1.
previously with activated SAKR cells (Siegelman et al., Exchange of the Cytoplasmic Domain of CD44
with that from a Disparate Adhesion Molecule2000). In addition, AKR-WT was able to both roll and
firmly adhere on HA  VCAM-1 but not on control HA  Does Not Restore Either Association
with VLA-4 or Firm AdhesionICAM-1. The diminished number of rolling cells observed
on HA VCAM-1 plates is consistent with the significant While the results of previous studies have been mixed
with respect to the role of the cytoplasmic domain innumber of cells undergoing firm adhesion. Treatment
with either EDTA or the blocking 4 antibody PS/2 abro- various CD44 functions, much of the recent evidence
has indicated a lack of a major contribution of the cyto-gated the observed sticking, substantiating the VLA-4
dependence. In contrast, AKR-TL cells were unable plasmic portion of CD44 to HA binding (Legg and Isacke,
1998; Lesley et al., 2000; Uff et al., 1999), consistentto bind firmly to HA  VCAM-1, and numbers of rolling
cells were increased compared to AKR-WT cells and with the above results. We proceeded to use a construct
in which the cytoplasmic domain of CD44 was ex-comparable to rolling on HA alone. Static adhesion
assays using soluble VCAM-1-coated plates demon- changed with sequences from human 5 integrin (CD44/
5CY) to see if there was a similar effect. This constructstrated that activated AKR-TLab cells adhere to VCAM-1
in the absence of shear stress (Alon et al., 1995; Moha- has been previously used to demonstrate the cyto-
plasmic sequence independence of HA binding (Lesleymadzadeh et al., 1998; Siegelman et al., 2000), indicating
that functional activation of the integrin in fact had oc- et al., 2000). The construct was transfected into AKR-1
cells stably transfected with 4 and 1, producing acurred (data not shown). The lack of firm adhesion with
these cells together with the loss of physical association line expressing the chimeric CD44 construct plus VLA-4
(AKR-CD445CY). The expression levels of CD49dseen in the immunoprecipitation analyses strongly sug-
gests the functional coordination of CD44 binding to and CD29 on this transfectant were comparable to that
of AKR-WT (Figure 4B) and, as shown by others (Les-VLA-4 and subsequent firm adhesion on VCAM-1 is criti-
cally dependent on the cytoplasmic tail of CD44. ley et al., 2000), CD44 expression and Fl-HA binding
Immunity
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Figure 2. Expression of CD44, VLA-4, and
LFA-1 in Murine T Cell Transfectants
Cell lines were activated using PMA/iono-
mycin for 18 hr, and PE- or FITC-conjugated
antibodies were added to cells in PBS/2%
FCS and incubated on ice for 20 min. The
cells were washed and analyzed by flow cy-
tometry. Transfection of BW5147 with 4
results in the expression of 41. AKR-WT
(full-length CD44) and AKR-TL (cytoplasmic-
deleted CD44) also express equivalent amounts
of VLA-4 after transfection with 4 and 1
cDNAs, while parental AKR-1 is negative for
both CD44 and VLA-4.
were indistinguishable from full-length CD44 transfec- AKR-WT transfectants. On HA VCAM-1, AKR-WT
tants (data not shown). cells rolled at velocities approximately 50% slower than
The results of laminar flow analysis of AKR- on HA alone, suggesting that a contribution to the modu-
CD445CY on HA  VCAM-1 were identical to those lation of rolling interactions is made by VLA-4 interacting
obtained with the truncated AKR-TL transfectant, with VCAM-1 (Figure 5A). This decrease is not apparent
with significant levels of rolling evident but with firm when comparing AKR-TL rolling on HA versus HA 
adhesion barely detectable (Figure 4A). Immunoprecipi- VCAM-1 (Figure 5B), suggesting that when CD44 and
tations were performed to examine whether the 5 cyto- VLA-4 are untethered the VLA-4/VCAM-1 interactions
plasmic tail would support the physical association of not only do not support firm adhesion but also do not
VLA-4 and CD44. Precipitation with anti-VLA-4 followed substantially contribute to rolling. In addition, on HA
by blotting with anti-CD44 resulted in the absence of a alone, rolling velocities of AKR-TL cells are slightly
CD44 band in the AKR-CD445CY transfectant, sug- increased compared to AKR-WT, perhaps reflecting
gesting the lack of any association (Figure 4C, left). The a decreased avidity of CD44 for ligand. Together, the
reciprocal experiment likewise shows no evidence of a data suggest that the association between full-length
physical association between VLA-4 and the CD445CY CD44 and VLA-4 leads to more avid rolling interactions
chimera (Figure 4C, right). As in Figures 1 and 3, associa- as well as firm adhesion and that the absence of this
tion of CD44 and VLA-4 bands is seen in AKR-WT interaction in the cytoplasmic tail deletant precludes the
precipitates but not in those from AKR-TL. Thus, the bio- contribution of VLA-4 to rolling as well as firm adhesion.
chemical and functional behaviors of AKR-CD445CY
and AKR-TL are quite similar. These results further
Cytochalasin D Inhibits VLA-4-Dependent Firmstrongly substantiate that specific sequences within the
Adhesion following CD44-Mediated Rollingcytoplasmic domain of CD44 are responsible for the
but Does Not Affect Physical Associationassociation between CD44 and VLA-4, that this associa-
between CD44 and VLA-4tion enables firm adhesion, and imply a discrete biologi-
It is well established that integrin function is frequentlycal function for the cytoplasmic domain of the CD44 mol-
closely linked to the actin cytoskeleton, and on lympho-ecule.
cytes the cytoskeleton has been suggested to regulate
integrin clustering (Kucik et al., 1996). To address theThe 41/VCAM-1 Interaction Results in Decreased
role of the actin cytoskeleton in the CD44/VLA-4 associ-Rolling Velocities on HA  VCAM-1 when Expressed
ation and in VLA-4 adhesive function, we used cytocha-in Conjunction with Full-Length but Not Tailless CD44
lasin D to disrupt actin polymerization shortly beforeIn addition to the change in the firm adhesion phenotype,
alteration in rolling behavior was also observed in the laminar flow analysis. Figure 6A shows that rolling inter-
Physical Association of CD44 and VLA-4 in Adhesion
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D, suggesting that the link between CD44 and VLA-4 is
not maintained indirectly through actin polymerization
and that the effect of cytochalasin D on firm adhesion
is distal to this association in the adhesion pathway.
In Vivo Confirmation of a Role for the Association
of CD44 and VLA-4 in Extravasation
using a Short-Term Homing Model
To extend these findings to an in vivo model, we utilized
a short-term homing assay that has been used pre-
viously to demonstrate both the CD44 and VLA-4 depen-
dence of activated T cell trafficking to an inflamed site
(DeGrendele et al., 1997b; Siegelman et al., 2000). Acti-
vated LNC, AKR-WT, or AKR-TL was labeled with
CFDA-SE and injected i.v. into Balb/c recipients that
had received i.p. SEB or PBS 20 hr previously. FACS
analysis of peritoneal exudate collected 90 min after
i.v. cell injection revealed entry of AKR-WT into the
inflamed peritoneum at levels comparable to SEB-acti-
vated LNC (Figure 7). The VLA-4 dependence of the
trafficking of this cell line was demonstrated using
blocking anti-VLA-4 antibody, while the control anti-H-2
had no effect. However, AKR-TL was defective in
trafficking to inflamed peritoneal cavities. Since these
cell lines differ only in the presence or absence of the
CD44 cytoplasmic tail, the results suggest a role for this
domain in the process of extravasation. CD44 depen-
dence is shown by antibody blocking of SEB-activated
LNC from normal mice and impaired trafficking of LNC
from CD44-deficient mice (Figure 7). These results fur-
ther support the biochemical and laminar flow evidenceFigure 3. Coprecipitation Analyses Suggest Full-Length CD44 Is
Required for the Association with VLA-4 presented here and demonstrate an in vivo relevance
(A) Samples were precipitated with anti-VLA-4 and blots were devel- of these observations for leukocyte extravasation.
oped with anti-CD44-biotin. Anti-CD44 detected a band in precipi-
tates from SAKR, BW, and AKR-WT but not from AKR-TL or Discussion
parental controls.
(B) Samples were precipitated with anti-CD44 and blots were devel-
The experiments presented here provide a biochemicaloped with anti-VLA-4-biotin. Bands corresponding to the 150 kDa
basis and mechanistic explanation for the observation chain and its 80 kDa degradation product were detected from
SAKR, BW, and AKR-WT but not from BW5147, AKR-WT, or that both murine and human T cell extravasation initiated
AKR-TL. by the activated form of CD44 selectively depends on
VLA-4 for firm adhesion and migration into extravascular
tissues. Normal murine T cells and murine and human
lymphoid cell lines bear CD44 that is physically associ-actions using the AKR-WT cell line are not substan-
tially affected by cytochalasin D on HA  VCAM-1 sub- ated with VLA-4 but not LFA-1 on the plasma membrane.
Disengagement of these two molecules on the surfacestrate. Rolling velocities were somewhat slowed com-
pared to untreated cells by up to 2-fold compared to occurs when the cytoplasmic portion of CD44 is deleted
or replaced with foreign sequences, with the functionalDMSO controls (data not shown), consistent with in-
creased plasma membrane pliability as previously ob- consequence that CD44-mediated rolling is preserved
but subsequent VLA-4-mediated firm adhesion onserved with selectin-mediated rolling (Yago et al., 2002).
However, sticking of AKR-WT cells on HA  VCAM-1 VCAM-1 is abrogated. This suggests that coassociation
of CD44 and VLA-4 is required for the latter to performis essentially abrogated, indicating a requirement for the
actin cytoskeleton in the firm adhesion step. its adhesive function in this adhesion pathway and dem-
onstrates that primary and secondary adhesion mole-To determine whether defective firm adhesion after
cytochalasin D was related to the requirement for asso- cules collaborate through direct physical association.
There has been accruing evidence suggesting that mol-ciation of CD44 and VLA-4, coimmunoprecipitations
with anti-VLA4 were performed after treatment of AKR- ecules considered classically to mediate either primary
or secondary adhesion often display overlapping rolesWT (control) and AKR-WT with varying concentra-
tions of cytochalasin D or DMSO for 20 min. Probing of and contribute to both (Forlow et al., 2000; Jung et al.,
1998; Kadono et al., 2002). However, the observationsblots with anti-CD44 showed a clear band in anti-VLA-4
immunoprecipitates from AKR-WT at all concentra- here depart significantly from previous paradigms in that
primary and secondary adhesion molecules must betions of cytochalasin D, and no substantial alteration in
band intensities is noted with increasing concentrations physically coanchored for firm adhesion to ensue.
The role of the CD44 cytoplasmic domain has been(Figure 6B). Thus, the physical association of CD44 and
VLA-4 is not disrupted in the presence of cytochalasin studied in some detail, particularly as regards the regula-
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Figure 4. Primary and Secondary Adhesion of CD44/VLA-4-Transfected Cell Lines on Soluble Substrates under Physiologic Shear Stress
(A) All AKR transfectants rolled on both HA and HA  VCAM-1. AKR-WT firmly adhered on HA  VCAM-1-coated plates, but firm adhesion
with AKR-TL was only slightly above background. Both anti-VLA-4 and 5 mM EDTA blocked sticking of AKR-WT without affecting rolling.
AKR-CD445CY also showed exclusively rolling interactions on HA VCAM-1-coated plates. Results are presented as percentage of 100%
control AKR-WT rolling (solid bars) or sticking (hatched bars) interactions, indicated with asterisk.
(B) The AKR-CD445CY transfectant (line) expresses CD29 and CD49d at levels essentially identical to AKR-WT (bold line).
(C) Precipitation analysis of AKR-CD445CY confirms that the CD44 cytoplasmic tail is required for the association with VLA-4. Samples
were precipitated with anti-VLA-4 and blots were developed with anti-CD44-biotin (left) or samples were precipitated with anti-CD44 and
blots developed with anti-VLA-4-biotin (right). CD44 and VLA-4 were detected in precipitates from AKR-WT but not from either AKR-TL
or AKR-CD445CY.
tion of HA binding, but various aspects remain contro- and 325 (Pure et al., 1995), which are constitutively phos-
phorylated (Neame and Isacke, 1992), two clusters ofversial. Initial studies with a cell line transfected with
wild-type CD44 bound HA constitutively, whereas a basic residues near the transmembrane domain (Lesley
et al., 2000; Liu and Sy, 1996), and a 15 aa purportedtransfectant with CD44 containing a cytoplasmic do-
main truncated to include only the membrane-proximal ankyrin binding domain, N304-L318 (Lesley et al., 2000;
Lokeshwar et al., 1994). In contrast, other studies havesix amino acids showed greatly reduced binding to solu-
ble HA (Lesley et al., 1992). Other experiments sug- suggested that these features were not required for effi-
cient HA binding to occur, since mutation of the serinesgested that certain features within the cytoplasmic do-
main were required for efficient HA binding: serines 323 (Lesley et al., 2000; Uff et al., 1999) or the basic residue
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Figure 5. Velocity Distribution of CD44/VLA-
4-Transfected Cell Lines at a Wall Shear
Stress of 2.0 Dynes/cm2
The frequency of cells within each velocity
range was calculated as a percent of the total
number of cells evaluated.
(A) AKR-WT cells on substrates HA (solid
bars) and HA  VCAM-1 (hatched bars). A
distinct shift to slower rolling velocities on
HA  VCAM-1 is seen.
(B) AKR-TL cells on substrates HA (solid
bars) and HA  VCAM-1 (hatched bars). No
shift in rolling velocities is seen.
clusters (Legg and Isacke, 1998) had no effect on HA The CD44 ezrin binding site has been mapped to clusters
of basic amino acids in a membrane-proximal regionbinding. Likewise, constructs with deletions encom-
passing these regions as well as the ankyrin binding within the cytoplasmic domain (Yonemura et al., 1998).
While VLA-4 has not been specifically investigated withdomain have been shown not to alter HA binding
(Perschl et al., 1995). Other chimeric constructs con- regard to ERM binding, the tailless construct utilized in
these studies is truncated prior to most of the positivelysisting of the CD44 extracellular domain and the trans-
membrane plus cytoplasmic domains of 5 integrin- charged intracytoplasmic residues (only the first three
Arg residues are present; Perschl et al., 1995). Sincebound HA as well as wild-type CD44, indicating that the
specific sequences of the cytoplasmic and transmem- it has been demonstrated that the second cluster of
positively charged residues is necessary for ERM bind-brane domains are not critical for HA binding (Lesley et
al., 2000). The high degree of conservation of sequence ing (Legg and Isacke, 1998), it would be expected that
ERM binding would be absent. The possibility that thehomology in the CD44 cytoplasmic domain among
mammalian species, 85% in the cytoplasmic domain association is driven through the actin cytoskeleton is
unlikely, however, since cytochalasin D treatment ofand 100% in transmembrane, implies conservation of
essential functions. Our experience with the cytoplasmic AKR-WT did not disrupt CD44/VLA-4 association, al-
though firm adhesion was dramatically affected (Figurevariant cell lines in these studies have shown character-
istics of both soluble HA binding and CD44/HA-depen- 6A). The precise mapping of the structural requirements
for VLA-4 binding and the possibility that additionaldent rolling similar to the full-length transfectants. While
the preponderance of evidence suggests sequence- adaptor proteins are involved will require further investi-
gation.specific elements of the cytoplasmic domain are largely
dispensable for the ligand binding state of the external Why an association between CD44 and VLA-4 would
be required for firm adhesion and subsequent extrava-domain of CD44, we would propose from these studies
that these sequences may be important for preserving sation is currently unclear. In other adhesion cascades
involving first selectins and their ligands and then integ-linkage to VLA-4, either directly or indirectly through
adaptor protein or cytoskeletal associations, and that rins, such associations have not been described. The
CD44-initiated adhesion pathway may be consideredthis has functional consequences.
Whether the linkage between CD44 and VLA-4 (either unique as its initial step depends on interaction with
a glycosaminoglycan, an elongated linear polymerized or  chain) cytoplasmic domains is direct or indirect
will require further investigation. However, it has been carbohydrate on endothelial cells, rather than mem-
brane-anchored glycoproteins or proteoglycans usedestablished that CD44 is a major protein linked to the
actin cytoskeleton through adaptor proteins present in for selectin interactions and initial tethering and rolling.
Thus, the presence of HA on endothelial cells with itsmembrane-cytoskeletal junctional complexes, the ERM
proteins ezrin, radixin, and moesin (Tsukita et al., 1994). highly multivalent repeating disaccharide may be analo-
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be required of CD44 until VCAM-1 is encountered and
firm adhesion can ensue. Coanchoring of CD44 and
VLA-4 could also assure that these adhesion partners
are present together in appropriate microdomains, such
as microvilli or lipid rafts, where access to the endothe-
lial surface is optimized. While chemokine activation of
VLA-4 may be necessary under these suboptimal T cell
activation conditions, such requirements may be by-
passed under conditions of full activation as used in our
in vitro studies here. However, it is likely that chemokines
from endothelial cells or underlying tissues, cytokine-
dependent milieu, or microenvironmental cation con-
centration effects play a role in vivo if integrin activation
is not sufficiently achieved by TCR stimulation alone.
The association of CD44 with key T cell signaling mole-
cules (Dianzani et al., 1999; Ilangumaran et al., 1998)
may support such a possibility.
While originally envisioned as a series of discrete sep-
arable events, the multistep paradigm of leukocyte ex-
travasation has evolved to incorporate participation of
what has previously been thought to be dedicated pri-
mary and secondary adhesion molecules to both adhe-
sion phases for selectin and integrin interactions. The
studies presented here address the mechanistic basis
for the selective and cooperative interaction between
CD44 and VLA-4 in a CD44-initiated pathway of T cell
extravasation. We show that these two molecules are
physically associated on the cell surface and that the
cytoplasmic portion of CD44 is necessary for this asso-
ciation. Disruption of the association through deletion
Figure 6. Firm Adhesion but Not Physical Association of CD44 with
of the CD44 cytoplasmic tail concordantly prevents firmVLA-4 Is Disrupted by Cytochalasin D
adhesion of VLA-4 on its ligand VCAM-1 under shear
(A) AKR-WT cells were analyzed by laminar flow and results are
stress, while leaving rolling interactions between CD44presented as percentage of 100% control rolling or sticking interac-
and HA intact. These observations fundamentally altertions of AKR-WT (*). Pretreatment of AKR-WT cells with 10 M
cytochalasin D had no effect on rolling (solid bars) but substantially the model of leukocyte adhesion to include a require-
inhibited firm adhesion (hatched bars) on HA  VCAM-1. ment for primary and secondary adhesion molecules to
(B) Analysis of the physical association of CD44 with VLA-4 after exist in a single bimolecular complex to achieve irrevers-
treatment with cytochalasin D. After stimulation, cells were incu- ible firm adhesion. Thus, regulation of the assembly/
bated in 0 (DMSO control, 0.1%), 10, 50, or 100 M cytochalasin D.
disassembly of this complex may provide a critical con-Membranes were prepared as described, precipitated with anti-
trol point influencing leukocyte adhesion and migration.VLA-4, and blots were developed with anti-CD44-biotin. Anti-CD44
detected CD44 in VLA-4 precipitates from AKR-WT irrespective These observations help to further clarify the frequent
of cytochalasin D treatment. association of both of these adhesion receptors with
diverse chronic inflammatory processes and suggest
that targeting of this bimolecular complex with a singlegous to a more continuous “coating” of endothelial sur-
agent may be feasible.faces in contradistinction to a disperse distribution of
individual (or clustered) selectin ligands. If a uniform
Experimental Proceduresdistribution of HA is also the case on endothelium, then
the limiting molecule for firm adhesion and subsequent Reagents
extravasation would be the encounter of VCAM-1 ligand. CHAPS detergent, cytochalasin D, phorbol myristic acid, rooster
Such a proximal arrangement of leukocyte primary and comb sodium hyaluronate, and staphylococcal enterotoxin B were
purchased from Sigma-Aldrich Chemical Company. (St. Louis, MO).secondary adhesion molecules would be disadvanta-
CFDA-SE [5-(and-6)-carboxyfluorescein diacetate succinimidyl es-geous to adhesion in other pathways where endothelial
ter] was obtained from Molecular Probes (Eugene, OR) and iono-ligands may not necessarily be colocalized. The advan-
mycin from Calbiochem-Novabiochem Corp. (La Jolla, CA). Fluores-
tages to such an association may be due to effects of ceinated HA was prepared as described (de Belder and Wik, 1975).
clustering for adhesive bond formation and enhance-
ment. Under conditions of high inflammatory stimulus, Antibodies and Soluble Protein
Phycoerythrin-conjugated Streptavidin and the following conju-VCAM-1 expression may be dense, and therefore, VLA-4/
gated and/or purified anti-mouse antibodies were purchased fromVCAM-1 interactions may be sufficient to support all
BD Pharmingen (San Diego, CA): CD11a (integrin L; M17/4 andthe steps of extravasation. Alternatively, CD44 could be
2D7), CD29 (integrin 1; Ha2/5), CD44 (non-HA-blocking IM7),required to effect and assure initial attachment (teth-
CD49d (integrin 4; 9C10), as well as anti-human CD11a (G43-25B)
ering), which could then be followed by immediate VLA- and CD49d (9F10). The HA-blocking rat anti-mouse CD44 hybridoma
4-dependent firm adhesion. At lower densities of KM81 was obtained from the American Type Culture Collection
(ATCC, Manassas, VA). Monoclonal rat anti-mouse and human VLA-VCAM-1, both the tethering and rolling functions may
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Figure 7. Short-Term Homing of T Cells into
an Inflamed Site
Fluorescent AKR-WT, AKR-TL, or acti-
vated LNC from SEB-treated donor mice
were injected intravenously into either PBS-
or SEB-treated recipient animals. Cells were
recovered from recipient mice by peritoneal
lavage and analyzed by FACS for CFDA fluo-
rescence to determine the number of trans-
ferred cells present in the peritoneal cavities.
Data are shown as the number of fluorescent
cells/200,000 cells analyzed and represent
the mean values  SEM from at least three
separate experiments (n  8). Control LNC
are found in the peritoneal cavities of SEB
but not PBS-treated recipients, as previously
described (DeGrendele et al., 1997b), and
blocking anti-CD44 inhibited their entry (p 
0.05). In addition, activated LNC from CD44-
deficient mice showed impaired trafficking to
this site. AKR-WT cells are also found in significant numbers in the peritoneal cavities of SEB-treated recipients but not in PBS-treated
recipients (p  0.05). Anti-VLA-4 blocked entry of AKR-WT cell (p  0.005). Fluorescent cells were found at only background levels in SEB-
treated recipient mice receiving AKR-TL cells (p  0.058), suggesting impairment in the ability of these cells to traffic to an inflamed site.
4 chain antibody (PS/2) was a kind gift from P. Kincade (Oklahoma Immunoprecipitation and Western Blot Analysis
Cells were grown in RPMI 1640/10% FCS or prepared freshly fromMedical Research Foundation, Oklahoma City, OK). The rat anti-
mouse pan-H-2 (M1/42) hybridoma was the generous gift of Dr. lymph nodes of Balb/c mice and stimulated with 10 ng/ml PMA and
500 ng/ml Ionomycin for 18–24 hr at 37	C. For in vivo-activatedKirsten Fischer-Lindahl, UTSWMCD. Polyclonal rabbit anti-human
and mouse L and goat anti-rabbit horseradish peroxidase were lymph node cells, Balb/c mice were injected i.p. with 50 g SEB 20
hr prior to harvest of MLN. Cell lysates were sonicated briefly andobtained from from Santa Cruz Biotechnology (Santa Cruz, CA).
Recombinant soluble human VCAM-1 was purchased from R & membranes prepared by centrifugation at 100,000 
 g (Visweswar-
iah et al., 1994). Pellets were resuspended in immunoprecipitationD Systems (Minneapolis, MN). A cell line producing recombinant
soluble murine ICAM-1 was a gift from F. Takei (University of British buffer with detergent (50 mM Tris [pH 8.0], 5 mM EDTA, 1 mM phenyl-
methylsulfonylfluoride, 1% CHAPS). After antibody addition, immuneColumbia, Vancouver, Canada). Mouse ICAM-1 was purified at 4	C
by passing culture supernatant through an anti-ICAM-1 antibody complexes were precipitated using protein A-Sepharose or strep-
tavidin-Sepharose, then eluted and analyzed by SDS-PAGE on 10%affinity column.
polyacrylamide gels under reducing conditions, followed by transfer
to nitrocellulose. Membranes were probed with biotinylated primaryCell Lines and Generation of CD44 and VLA-4 Transfectants
antibody for 4 hr at room temperature. Blots were washed 3
 forThe murine T cell lines SAKR and AKR-1, as well as AKR-1 cells
1 hr with PBS/0.1% Tween 20/100 mM NaCl and developed withtransfected with either full-length murine CD44 cDNA (AKR-WT) or
a chemiluminescence kit using streptavidin-peroxidase (SA-POD;the cytoplasmic tail deletant of murine CD44 (AKR-TL) (Lesley et
Boehringer-Mannheim, Indianapolis, IN) or, where noted, goat anti-al., 1992) were gifts from J. Lesley (Salk Institute, La Jolla, CA). The
rabbit IgG-HRP.human EBV-transformed B-lymphoblastoid cell line KCA was kindly
For cytochalasin D treatment, cells were stimulated for 18 hr usingprovided by Dr. L. Picker (University of Oregon Health Science Cen-
PMA/ionomycin, washed, and incubated for 20 min at room temper-ter, Portland, OR). The human myelomonocytic cell line U937 and
ature in serum-free RPMI/0.1% DMSO or in 10, 50, or 100 M cyto-the murine AKR/J thymoma line BW5147 were obtained from the
chalasin D in serum-free RPMI/0.1% DMSO. Cells were then washedATCC. Murine lymph node cells were isolated from mesenteric
in RPMI and used for adhesion experiments or membranes werelymph nodes of female BALB/c mice.
prepared as described for immunoprecipitation.Murine VLA-4  chain cDNA in pBluescriptSK was a kind gift of
Dr. Brad McIntyre (University of Texas MD Anderson Cancer Center,
Houston, TX) and was subcloned into the pcDNA3.1/Zeo expres- Adhesion Assay under Flow Conditions
Rolling and firm adhesion of lymphocytes was assessed on a parallelsion vector (Invitrogen Life Technologies, Carlsbad, CA).  chain
cDNA in the pGEM vector (Promega Corp., Madison, WI) was the gift plate flow chamber under physiologic flow conditions as described
(DeGrendele et al., 1996). In brief, a 35 mm tissue culture dish wasof Dr. Bernard Holzmann (Technische Universitat Munchen, Munich,
Germany). VLA-4  and  chain cDNAs were transfected into AKR- coated with 1 ml of 2.5 mg/ml of HA in PBS overnight at 4	C, then
with 1 ml of 1 g/ml VCAM-1 or ICAM-1 (substrate control) in aWT and AKR-TL cells by electroporation and selected with 100 g/
ml zeocin (Invitrogen). BW5147 cells (CD44 and 1 expressing) solution of 10 mM NaHCO3 in PBS (pH 9.1) for 2 hr at room tempera-
ture on a rocking platform. Cells were resuspended at a concentra-were transfected with the integrin 4 construct only. Selection of
stable transfectants was accomplished by staining with anti-CD49d- tion of 2
 106 cells/ml in RPMI 1640 and pulled continuously through
the flow chamber by means of a Harvard syringe pump at flow ratesPE followed by sorting using a FACSVantageTM (Becton Dickinson);
flow cytometric analysis was performed using a FACScanTM analyti- of 0.2 ml/min (2 dynes/cm2). Blocking of adhesion was done by
incubating the cells with saturating concentrations of antibody forcal instrument.
The CD445CY hybrid construct made by Perschl et al. (Lesley 10 min before the adhesion assay or by adding EDTA to 5 mM
immediately prior to the assay. Interaction of cells with the surfaceet al., 2000; Perschl et al., 1995) was kindly provided by Jayne
Lesley and Robert Hyman, Salk Institute, and Katalin Mikecz, Rush of the plates was monitored using a Nikon Diaphot-TMD-inverted
phase contrast microscope connected to a video camera and re-University Medical Center. The construct contains the extracellular
and transmembrane domains of murine CD44, followed by the cyto- corder.
For quantitation, rolling cells from at least four separate fieldsplasmic domain of human 5 integrin in the mammalian transfection
vector pRc/RSV (Invitrogen). AKR-1 cells were transfected with 4 were counted for 1 to 2 min per field. Firm adhesion was determined
by counting total cells firmly adherent on four discrete fields afterand 1 chain constructs followed by the CD445CY construct;
clones were selected in the presence of zeocin plus G418 for expres- four minutes of flow. Each interaction condition was analyzed with
at least three samples. The average was calculated and results aresion of CD44 along with both VLA-4 chains.
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shown as percentage of positive control interaction (either rolling de Belder, A.N., and Wik, K.O. (1975). Preparation and properties
of fluorescein-labeled hyaluronate. Carbohydr. Res. 44, 251–257.or sticking). Cell rolling velocities were obtained by determining the
amount of time necessary for a given cell to move a calibrated DeGrendele, H.C., Estess, P., Picker, L.J., and Siegelman, M.H.
distance. For average velocity and velocity distributions, at least (1996). CD44 and its ligand hyaluronate mediate rolling under physi-
100 cells from two separate experiments for each experimental con- ologic flow: a novel lymphocyte/endothelial cell primary adhesion
dition were followed. pathway. J. Exp. Med. 183, 1119–1130.
DeGrendele, H.C., Estess, P., and Siegelman, M.H. (1997a). CD44
Animals activation and associated primary adhesion is inducible via T cell
Female Balb/c mice were bred in the animal facility of the University receptor stimulation. J. Immunol. 159, 2549–2553.
of Texas Southwestern Medical Center at Dallas under SPF condi-
DeGrendele, H.D., Estess, P., and Siegelman, M.H. (1997b). Require-tions and used between the ages of 10 and 12 weeks. CD44-deficient
ment for CD44 in activated T cell extravasation into an inflamedmice (Protin et al., 1999; Schmits et al., 1997) were purchased from
site. Science 278, 672–675.The Jackson Laboratory (Bar Harbor, ME).
Dianzani, U., Bragardo, M., Tosti, A., Ruggeri, L., Volpi, I., Casucci,
M., Bottarel, F., Feito, M.J., Bonissoni, S., and Velardi, A. (1999).Short-Term Homing Assay
CD44 signaling through p56(lck) involves lateral association withShort-term homing of fluorescent-labeled murine lymph node cells
CD4 in human CD4() T cells. Int. Immunol. 11, 1085–1092.or AKR-1 transfectants was performed as described (DeGrendele
et al., 1997b; Estess et al., 1999) with minor modifications. Donor Estess, P., DeGrendele, H.C., Pascual, V., and Siegelman, M.H.
Balb/c or CD44-deficient mice were injected i.p. with 50 g of SEB (1998). Functional activation of lymphocyte CD44 in peripheral blood
in 300 l of PBS. After 20 hr, MLN were removed and cells were is a marker of autoimmune disease activity. J. Clin. Invest. 102, 1173–
fluorochrome labeled in 2 m CFDA-SE. Fluorescent donor cells 1182.
(2
 107/mouse) were transferred i.v. into Balb/c mice that had been Estess, P., Nandi, A., Mohamadzadeh, M., and Siegelman, M.H.
injected i.p. 20 hr previously with 500 l PBS or SEB (50 g). Some (1999). IL-15 induces endothelial hyaluronan expression in vitro and
recipients were also given 200 g blocking KM81 anti-CD44 at the promotes activated T cell extravasation through a CD44 dependent
time of LNC cell injection. Experiments using AKR-WT or AKR- pathway in vivo. J. Exp. Med. 190, 9–19.
TL transfectants were conducted in similar fashion except that
Forlow, S.B., White, E.J., Barlow, S.C., Feldman, S.H., Lu, H., Bagby,increased numbers (5 
 107) of CFDA-SE-labeled cells were used.
G.J., Beaudet, A.L., Bullard, D.C., and Ley, K. (2000). Severe inflam-After 90 min, recipient mice were sacrificed, and cells in the perito-
matory defect and reduced viability in CD18 and E-selectin double-neal cavity were collected by lavage with 5 ml RPMI and 2 mM
mutant mice. J. Clin. Invest. 106, 1457–1466.EDTA and analyzed by flow cytometry for the presence of CFDA-
Ghosh, S., Goldin, E., Gordon, F.H., Malchow, H.A., Rask-Madsen,labeled donor cells. Some recipients of AKR-WT cells were also
J., Rutgeerts, P., Vyhnalek, P., Zadorova, Z., Palmer, T., and Do-given 200 g blocking anti-VLA-4 (PS/2) at the time of cell injection
noghue, S. (2003). Natalizumab for active Crohn’s disease. N. Engl.or a control antibody, pan-anti-H-2 (M1/42) (DeGrendele et al.,
J. Med. 348, 24–32.1997b). Two hundred thousand lymphocyte-gated events were col-
lected for each peritoneal lavage sample. Holzmann, B., McIntyre, B.W., and Weissman, I.L. (1989). Identifica-
tion of a murine Peyer’s patch-specific lymphocyte homing receptor
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